(Q54130985)

25 May 2018

review article

1 reference

title

Abnormal glucose metabolism in cystic fibrosis. (English)

1 reference

25 May 2018

0 references

Moran A

1

1 reference

25 May 2018

Doherty L

series ordinal

2

1 reference

25 May 2018

Wang X

series ordinal

3

1 reference

25 May 2018

Thomas W

series ordinal

4

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

25 May 2018

The Journal of Pediatrics

published in

1 reference

25 May 2018

volume

133

1 reference

25 May 2018

issue

1

1 reference

25 May 2018

page(s)

10-17

1 reference

25 May 2018

Diabetes mellitus associated with cystic fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Pathogenesis of NIDDM. A balanced overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Role of autoimmunity in insulinopenia and carbohydrate derangements associated with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Genetic determination of diabetes mellitus in patients with cystic fibrosis. Multicenter Cystic Fibrosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Insulin Secretion, Glycosylated Haemoglobin and Islet Cell Antibodies in Cystic Fibrosis Children and Adolescents with Different Degrees of Glucose Tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Diabetes mellitus in cystic fibrosis: genetic and immunological markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Glucose tolerance in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Glucose intolerance in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Pancreatic alpha and beta cell functions in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Carbohydrate Tolerance in Cystic Fibrosis Is Closely Linked to Pancreatic Exocrine Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Pancreatic endocrine function in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

The pathogenesis of insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

First-Phase Insulin Release in Adult Cystic Fibrosis Patients: Correlation with Clinical and Biological Parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Proinsulin, proinsulin intermediate and insulin in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Insulin sensitivity in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Insulin resistance is associated with decreased clinical status in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Elevated Hepatic Glucose Production in Children with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Increased energy expenditure in young children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Energy expenditure and genotype of children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Increased resting energy expenditure in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

The cystic fibrosis gene and resting energy expenditure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Increased energy expenditure in cystic fibrosis is associated with specific mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Cystic fibrosis associated islet changes may provide a basis for diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

The pancreas in cystic fibrosis: chemical composition and comparative morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Endocrine pancreas in cystic fibrosis: An immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Regulation of protein turnover in skeletal and cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Characteristics of pulmonary function in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

The interaction of 2 diseases: diabetes mellitus and cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Relative underweight in cystic fibrosis and its prognostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Whole body protein turnover in malnourished cystic fibrosis patients and its relationship to pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Nutritional Rehabilitation Increases Resting Energy Expenditure Without Affecting Protein Turnover in Patients with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Protein turnover and resting energy expenditure in patients with undernutrition and chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

Proteolysis associated with insulin resistance in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970171-4

10.1016/S0022-3476(98)70171-4

7 January 2021

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018